Liquid-biopsy-Analysen mithilfe zellfreier DNA (cfDNA)
- 22 September 2015
- journal article
- research article
- Published by Springer Nature in Der Pathologe
- Vol. 36 (6) , 572-578
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Phase II Trial (BREAK-2) of the BRAF Inhibitor Dabrafenib (GSK2118436) in Patients With Metastatic MelanomaJournal of Clinical Oncology, 2013
- BioCAST : le Bio-observatoire national du cancer bronchiques chez les patients non fumeurs (IFCT1002)Revue des Maladies Respiratoires, 2013
- Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screeningBreast Cancer Research, 2013
- Circulating Tumor Cells: Liquid Biopsy of CancerClinical Chemistry, 2013
- Emergence of KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerNature, 2012
- High-Throughput Droplet Digital PCR System for Absolute Quantitation of DNA Copy NumberAnalytical Chemistry, 2011
- Multiplexed Real-Time Polymerase Chain Reaction on a Digital Microfluidic PlatformAnalytical Chemistry, 2010
- Sequencing technologies — the next generationNature Reviews Genetics, 2009
- Sensitive digital quantification of DNA methylation in clinical samplesNature Biotechnology, 2009
- Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation AssayPLOS ONE, 2008